awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26801286-C8F1BA8E-96AB-41C7-9717-7FFD6C6E2109
Q26801286-C8F1BA8E-96AB-41C7-9717-7FFD6C6E2109
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26801286-C8F1BA8E-96AB-41C7-9717-7FFD6C6E2109
Resistance against Integrase Strand Transfer Inhibitors and Relevance to HIV Persistence
P2860
Q26801286-C8F1BA8E-96AB-41C7-9717-7FFD6C6E2109
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26801286-C8F1BA8E-96AB-41C7-9717-7FFD6C6E2109
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8d7a5d35baa8a1497459ffd06e273da9502941ba
P2860
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks